SCHEMBL3822202

SCHEMBL3822202

NCc1nnc(-c2cccc(O)c2)o1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.65
LMNA P02545 2/20 0.47
HSD17B1 P14061 6/20 0.46
HSD17B2 P37059 5/20 0.46
ALDH1A1 P00352 2/20 0.44
HDAC8 Q9BY41 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
POLB P06746 2/20 0.43
MECP2 P51608 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
GUSB P08236 1/20 0.42
ENPP2 Q13822 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3825286 0.88 NOTUM (0.55) NOTUMLMNAALDH1A1HDAC8NPC1
SCHEMBL8058379 0.84 LMNA (0.50) NOTUMLMNAHSD17B1HSD17B2ALDH1A1
SCHEMBL28531936 0.84 LMNA (0.65) NOTUMLMNAHSD17B1HSD17B2ALDH1A1
SCHEMBL1180155 0.82 HSD17B1 (0.59) LMNAHSD17B1HSD17B2ALDH1A1NPC1
SCHEMBL3822281 0.81 NOTUM (0.65) NOTUMLMNAALDH1A1HDAC8NPC1
SCHEMBL3821263 0.81 NOTUM (0.65) NOTUMLMNAALDH1A1NPC1RAB9A
SCHEMBL13933384 0.81 NOTUM (0.65) NOTUMLMNAALDH1A1NPC1RAB9A
SCHEMBL4652480 0.79 NOTUM (1.00) NOTUMLMNAALDH1A1HDAC8NPC1
SCHEMBL10299385 0.78 NPC1 (0.65) HSD17B1HSD17B2ALDH1A1NPC1RAB9A
SCHEMBL3825063 0.77 KDM4E (0.67) NOTUMLMNAALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 NOTUM 298/4885LMNA 2209/4885HSD17B1 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.